Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- Mitsubishi Tanabe Sales Up 6% on Radicava Oral Form
November 5, 2024
- Santen’s Glaucoma Med Rhopressa Hits Shelves in South Korea
November 5, 2024
- Mitsubishi to Take Another Stab at Parkinson’s Drug Submission in US
November 5, 2024
- LEO Pharma, Kyowa Kirin to Wind Up Dovobet Collaboration
November 5, 2024
- FDA Rolling Submission for Leqembi SC Completed: Eisai
November 5, 2024
- Takeda’s Japan Sales Ratio Falls Below 10%, Global Biz Thrives in H1
November 1, 2024
- Daiichi Sankyo Ups Outlook on Earnings Growth Driven by Enhertu
November 1, 2024
- Ono President Hopes to Turn Deciphera into Black in 2-3 Years
November 1, 2024
- Daiichi Sankyo Starts 3 Global PIII Trials of TROP2 ADC for NSCLC
November 1, 2024
- Kyowa Kirin Picks Abdul Mullick as New President and COO
November 1, 2024
- Otsuka Holdings Names Makoto Inoue as New CEO
November 1, 2024
- Ono’s H1 Revenue Falters 7% after Opdivo Price Cuts
November 1, 2024
- Mochida Bags Japan Rights to United Therapeutics’ Tyvaso DPI
November 1, 2024
- Tecentriq Filed for Rare Nasal Lymphoma in Japan: Chugai
November 1, 2024
- Astellas Records 22% Revenue Growth in 1H Riding on Strategic Assets
October 31, 2024
- Sumitomo’s FY2024 1H Results Meet Initial Plan amid Restructuring
October 31, 2024
- iPark to Hold 1st US Investor Confab to Woo VCs for Asian Startups
October 31, 2024
- Orion Japan to Take Back Parkinson’s Drugs from Novartis
October 31, 2024
- Leqembi’s July-September Sales Up 1.6-Fold QOQ: Eisai
October 31, 2024
- 604 Employees Raise Hands for Sumitomo’s Buyout Program
October 31, 2024
